Reported History of Measles and Long-term Impact on Antibody to Tetanus in Children 6–59 Months of Age Receiving DTP in the Democratic Republic of Congo Article Swipe
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1093/ofid/ofx163.761
Background Recent studies suggest a measles-induced immune amnesia that could have long-term immunosuppressive effects via preferential depletion of memory B and T CD150+ lymphocytes. Methods We examined the association between past measles and tetanus antibody levels among children participating in the 2013–2014 Democratic Republic of Congo (DRC) Demographic and Health Survey (DHS). Our sample consisted of 833 children aged 6–59 months whose mothers were selected for interview. Mothers reported (via recall) history of measles within the lifetime of the child. Classification of children who previously had measles was completed using maternal recall and measles immunoglobulin G (IgG) serostatus obtained via dried blood spot (DBS) analysis. A multiplex chemiluminescent immunoassay platform was used to obtain serologic results and Assay Score (AS) was calculated as a ratio to a positive control included in each run. Tetanus serostatus was categorized as being above or below the sample median serology AS value. Tetanus vaccination status was obtained via dated vaccination card and limited to children receiving the complete 3-dose vaccination series. Results The median AS for tetanus serology among the entire sample of 833 children was 0.085, while children with history of measles had a median AS of 0.053 (N = 41) and children with no history of measles had a median AS of 0.088 (N = 792), chi-square P-value < 0.05. A random intercept logistic regression model was used to examine the association between previous measles disease and odds of having below median levels of tetanus antibody. Controlling for potential confounding variables, the odds of a child with past history of measles having less than the median level of tetanus antibody was 3.86 (95% CI: 1.70, 8.78) among children fully vaccinated for tetanus. Conclusion The results suggest that, among children 6–59 months in DRC, measles may have a long-term impact on levels of pre-existing, vaccine-induced immunity to tetanus. These findings suggest the need for laboratory studies examining measles’ impact on pre-existing, vaccine-induced immunity and underscore the need for continued evaluation and improvement of DRC’s measles vaccination program. Disclosures All authors: No reported disclosures.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/ofid/ofx163.761
- https://academic.oup.com/ofid/article-pdf/4/suppl_1/S323/20490161/ofx163.761.pdf
- OA Status
- gold
- Cited By
- 4
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2754119027
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2754119027Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/ofid/ofx163.761Digital Object Identifier
- Title
-
Reported History of Measles and Long-term Impact on Antibody to Tetanus in Children 6–59 Months of Age Receiving DTP in the Democratic Republic of CongoWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2017Year of publication
- Publication date
-
2017-01-01Full publication date if available
- Authors
-
Hayley R. Ashbaugh, James D. Cherry, Sue Gerber, Stephen G. Higgins, Adva Gadoth, Vivian H. Alfonso, Patrick Mukadi, Nicole A. Hoff, Reena H. Doshi, Anne W. RimoinList of authors in order
- Landing page
-
https://doi.org/10.1093/ofid/ofx163.761Publisher landing page
- PDF URL
-
https://academic.oup.com/ofid/article-pdf/4/suppl_1/S323/20490161/ofx163.761.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/ofid/article-pdf/4/suppl_1/S323/20490161/ofx163.761.pdfDirect OA link when available
- Concepts
-
Medicine, Measles, Tetanus, Serostatus, Vaccination, Pediatrics, Serology, Immunology, Logistic regression, Antibody, Internal medicine, Viral load, Human immunodeficiency virus (HIV)Top concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 1, 2021: 1, 2020: 1, 2019: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2754119027 |
|---|---|
| doi | https://doi.org/10.1093/ofid/ofx163.761 |
| ids.doi | https://doi.org/10.1093/ofid/ofx163.761 |
| ids.mag | 2754119027 |
| ids.openalex | https://openalex.org/W2754119027 |
| fwci | 0.26546842 |
| type | article |
| title | Reported History of Measles and Long-term Impact on Antibody to Tetanus in Children 6–59 Months of Age Receiving DTP in the Democratic Republic of Congo |
| biblio.issue | suppl_1 |
| biblio.volume | 4 |
| biblio.last_page | S323 |
| biblio.first_page | S323 |
| topics[0].id | https://openalex.org/T13410 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9977999925613403 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Immune responses and vaccinations |
| topics[1].id | https://openalex.org/T10833 |
| topics[1].field.id | https://openalex.org/fields/33 |
| topics[1].field.display_name | Social Sciences |
| topics[1].score | 0.9952999949455261 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3306 |
| topics[1].subfield.display_name | Health |
| topics[1].display_name | Vaccine Coverage and Hesitancy |
| topics[2].id | https://openalex.org/T10873 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9941999912261963 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2404 |
| topics[2].subfield.display_name | Microbiology |
| topics[2].display_name | Bacterial Infections and Vaccines |
| is_xpac | False |
| apc_list.value | 3064 |
| apc_list.currency | USD |
| apc_list.value_usd | 3064 |
| apc_paid.value | 3064 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3064 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8730053901672363 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2776438120 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8240439891815186 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q79793 |
| concepts[1].display_name | Measles |
| concepts[2].id | https://openalex.org/C2779841045 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7761365175247192 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q47790 |
| concepts[2].display_name | Tetanus |
| concepts[3].id | https://openalex.org/C2776535787 |
| concepts[3].level | 4 |
| concepts[3].score | 0.7709642648696899 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1084257 |
| concepts[3].display_name | Serostatus |
| concepts[4].id | https://openalex.org/C22070199 |
| concepts[4].level | 2 |
| concepts[4].score | 0.637212872505188 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q192995 |
| concepts[4].display_name | Vaccination |
| concepts[5].id | https://openalex.org/C187212893 |
| concepts[5].level | 1 |
| concepts[5].score | 0.533105731010437 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[5].display_name | Pediatrics |
| concepts[6].id | https://openalex.org/C45189115 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5154067277908325 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q502159 |
| concepts[6].display_name | Serology |
| concepts[7].id | https://openalex.org/C203014093 |
| concepts[7].level | 1 |
| concepts[7].score | 0.45573127269744873 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[7].display_name | Immunology |
| concepts[8].id | https://openalex.org/C151956035 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4122130870819092 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1132755 |
| concepts[8].display_name | Logistic regression |
| concepts[9].id | https://openalex.org/C159654299 |
| concepts[9].level | 2 |
| concepts[9].score | 0.30099454522132874 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[9].display_name | Antibody |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.23831138014793396 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C142462285 |
| concepts[11].level | 3 |
| concepts[11].score | 0.08143365383148193 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q2528140 |
| concepts[11].display_name | Viral load |
| concepts[12].id | https://openalex.org/C3013748606 |
| concepts[12].level | 2 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q15787 |
| concepts[12].display_name | Human immunodeficiency virus (HIV) |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8730053901672363 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/measles |
| keywords[1].score | 0.8240439891815186 |
| keywords[1].display_name | Measles |
| keywords[2].id | https://openalex.org/keywords/tetanus |
| keywords[2].score | 0.7761365175247192 |
| keywords[2].display_name | Tetanus |
| keywords[3].id | https://openalex.org/keywords/serostatus |
| keywords[3].score | 0.7709642648696899 |
| keywords[3].display_name | Serostatus |
| keywords[4].id | https://openalex.org/keywords/vaccination |
| keywords[4].score | 0.637212872505188 |
| keywords[4].display_name | Vaccination |
| keywords[5].id | https://openalex.org/keywords/pediatrics |
| keywords[5].score | 0.533105731010437 |
| keywords[5].display_name | Pediatrics |
| keywords[6].id | https://openalex.org/keywords/serology |
| keywords[6].score | 0.5154067277908325 |
| keywords[6].display_name | Serology |
| keywords[7].id | https://openalex.org/keywords/immunology |
| keywords[7].score | 0.45573127269744873 |
| keywords[7].display_name | Immunology |
| keywords[8].id | https://openalex.org/keywords/logistic-regression |
| keywords[8].score | 0.4122130870819092 |
| keywords[8].display_name | Logistic regression |
| keywords[9].id | https://openalex.org/keywords/antibody |
| keywords[9].score | 0.30099454522132874 |
| keywords[9].display_name | Antibody |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.23831138014793396 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/viral-load |
| keywords[11].score | 0.08143365383148193 |
| keywords[11].display_name | Viral load |
| language | en |
| locations[0].id | doi:10.1093/ofid/ofx163.761 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2735126445 |
| locations[0].source.issn | 2328-8957 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2328-8957 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Open Forum Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648 |
| locations[0].license | |
| locations[0].pdf_url | https://academic.oup.com/ofid/article-pdf/4/suppl_1/S323/20490161/ofx163.761.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Open Forum Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1093/ofid/ofx163.761 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:5632196 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | http://doi.org/10.1093/ofid/ofx163.761 |
| locations[2].id | pmh:oai:europepmc.org:4558563 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/5632196 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5071260826 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8530-0904 |
| authorships[0].author.display_name | Hayley R. Ashbaugh |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[0].affiliations[0].raw_affiliation_string | Epidemiology, University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| authorships[0].institutions[0].id | https://openalex.org/I161318765 |
| authorships[0].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of California, Los Angeles |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Hayley Ashbaugh |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Epidemiology, University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| authorships[1].author.id | https://openalex.org/A5103413418 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | James D. Cherry |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[1].affiliations[0].raw_affiliation_string | Pediatric Infectious Diseases, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California |
| authorships[1].institutions[0].id | https://openalex.org/I161318765 |
| authorships[1].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of California, Los Angeles |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | James D Cherry |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Pediatric Infectious Diseases, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California |
| authorships[2].author.id | https://openalex.org/A5079640597 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7621-162X |
| authorships[2].author.display_name | Sue Gerber |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1303444417 |
| authorships[2].affiliations[0].raw_affiliation_string | Bill and Melinda Gates Foundation, Seattle, Washington |
| authorships[2].institutions[0].id | https://openalex.org/I1303444417 |
| authorships[2].institutions[0].ror | https://ror.org/0456r8d26 |
| authorships[2].institutions[0].type | nonprofit |
| authorships[2].institutions[0].lineage | https://openalex.org/I1303444417 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Gates Foundation |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Sue Gerber |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Bill and Melinda Gates Foundation, Seattle, Washington |
| authorships[3].author.id | https://openalex.org/A5110598576 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Stephen G. Higgins |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210138617 |
| authorships[3].affiliations[0].raw_affiliation_string | OpGen Incorporated, Gaithersburg, Maryland |
| authorships[3].institutions[0].id | https://openalex.org/I4210138617 |
| authorships[3].institutions[0].ror | https://ror.org/03sm03s92 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210138617 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | OpGen (United States) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Stephen G Higgins |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | OpGen Incorporated, Gaithersburg, Maryland |
| authorships[4].author.id | https://openalex.org/A5044274978 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3217-2435 |
| authorships[4].author.display_name | Adva Gadoth |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[4].affiliations[0].raw_affiliation_string | University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| authorships[4].institutions[0].id | https://openalex.org/I161318765 |
| authorships[4].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | University of California, Los Angeles |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Adva Gadoth |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| authorships[5].author.id | https://openalex.org/A5110504062 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Vivian H. Alfonso |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[5].affiliations[0].raw_affiliation_string | University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| authorships[5].institutions[0].id | https://openalex.org/I161318765 |
| authorships[5].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | University of California, Los Angeles |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Vivian H Alfonso |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| authorships[6].author.id | https://openalex.org/A5035106562 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-9312-9345 |
| authorships[6].author.display_name | Patrick Mukadi |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[6].affiliations[0].raw_affiliation_string | University of California, Los Angeles, UCLA-DRC Research Program, Kinshasa, Congo (The Democratic Republic of the) |
| authorships[6].institutions[0].id | https://openalex.org/I161318765 |
| authorships[6].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | University of California, Los Angeles |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Patrick Mukadi |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | University of California, Los Angeles, UCLA-DRC Research Program, Kinshasa, Congo (The Democratic Republic of the) |
| authorships[7].author.id | https://openalex.org/A5062176115 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-1770-6304 |
| authorships[7].author.display_name | Nicole A. Hoff |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[7].affiliations[0].raw_affiliation_string | University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| authorships[7].institutions[0].id | https://openalex.org/I161318765 |
| authorships[7].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | University of California, Los Angeles |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Nicole Hoff |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| authorships[8].author.id | https://openalex.org/A5086248289 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-4631-9696 |
| authorships[8].author.display_name | Reena H. Doshi |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[8].affiliations[0].raw_affiliation_string | University of California, Los Angeles, UCLA-DRC Research Program, Los Angeles, California |
| authorships[8].institutions[0].id | https://openalex.org/I161318765 |
| authorships[8].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | University of California, Los Angeles |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Reena Doshi |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | University of California, Los Angeles, UCLA-DRC Research Program, Los Angeles, California |
| authorships[9].author.id | https://openalex.org/A5051618172 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0662-9067 |
| authorships[9].author.display_name | Anne W. Rimoin |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I161318765 |
| authorships[9].affiliations[0].raw_affiliation_string | University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| authorships[9].institutions[0].id | https://openalex.org/I161318765 |
| authorships[9].institutions[0].ror | https://ror.org/046rm7j60 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I161318765 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | University of California, Los Angeles |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Anne W Rimoin |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | University of California, Los Angeles, Fielding School of Public Health, Los Angeles, California |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/ofid/article-pdf/4/suppl_1/S323/20490161/ofx163.761.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Reported History of Measles and Long-term Impact on Antibody to Tetanus in Children 6–59 Months of Age Receiving DTP in the Democratic Republic of Congo |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T13410 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9977999925613403 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Immune responses and vaccinations |
| related_works | https://openalex.org/W2075010788, https://openalex.org/W2124140405, https://openalex.org/W2138426110, https://openalex.org/W2003666163, https://openalex.org/W1994465650, https://openalex.org/W2037102991, https://openalex.org/W1987455384, https://openalex.org/W4255718749, https://openalex.org/W2047973812, https://openalex.org/W4280495290 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2021 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2020 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2019 |
| counts_by_year[3].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1093/ofid/ofx163.761 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2735126445 |
| best_oa_location.source.issn | 2328-8957 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2328-8957 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Open Forum Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://academic.oup.com/ofid/article-pdf/4/suppl_1/S323/20490161/ofx163.761.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Open Forum Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1093/ofid/ofx163.761 |
| primary_location.id | doi:10.1093/ofid/ofx163.761 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2735126445 |
| primary_location.source.issn | 2328-8957 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2328-8957 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Open Forum Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648 |
| primary_location.license | |
| primary_location.pdf_url | https://academic.oup.com/ofid/article-pdf/4/suppl_1/S323/20490161/ofx163.761.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Open Forum Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1093/ofid/ofx163.761 |
| publication_date | 2017-01-01 |
| publication_year | 2017 |
| referenced_works_count | 0 |
| abstract_inverted_index.= | 197, 213 |
| abstract_inverted_index.A | 106, 219 |
| abstract_inverted_index.B | 20 |
| abstract_inverted_index.G | 96 |
| abstract_inverted_index.T | 22 |
| abstract_inverted_index.a | 5, 124, 127, 191, 207, 253, 295 |
| abstract_inverted_index.(N | 196, 212 |
| abstract_inverted_index.AS | 147, 171, 193, 209 |
| abstract_inverted_index.No | 338 |
| abstract_inverted_index.We | 26 |
| abstract_inverted_index.as | 123, 138 |
| abstract_inverted_index.in | 40, 131, 290 |
| abstract_inverted_index.no | 202 |
| abstract_inverted_index.of | 18, 45, 56, 73, 78, 82, 179, 188, 194, 204, 210, 237, 242, 252, 258, 266, 300, 330 |
| abstract_inverted_index.on | 298, 317 |
| abstract_inverted_index.or | 141 |
| abstract_inverted_index.to | 113, 126, 160, 227, 304 |
| abstract_inverted_index.41) | 198 |
| abstract_inverted_index.833 | 57, 180 |
| abstract_inverted_index.All | 336 |
| abstract_inverted_index.CI: | 272 |
| abstract_inverted_index.Our | 53 |
| abstract_inverted_index.The | 169, 282 |
| abstract_inverted_index.and | 21, 33, 49, 93, 117, 158, 199, 235, 321, 328 |
| abstract_inverted_index.for | 66, 172, 246, 279, 311, 325 |
| abstract_inverted_index.had | 86, 190, 206 |
| abstract_inverted_index.may | 293 |
| abstract_inverted_index.the | 28, 41, 76, 79, 143, 163, 176, 229, 250, 263, 309, 323 |
| abstract_inverted_index.via | 15, 100, 154 |
| abstract_inverted_index.was | 88, 111, 121, 136, 152, 182, 225, 269 |
| abstract_inverted_index.who | 84 |
| abstract_inverted_index.(95% | 271 |
| abstract_inverted_index.(AS) | 120 |
| abstract_inverted_index.(via | 70 |
| abstract_inverted_index.3.86 | 270 |
| abstract_inverted_index.DRC, | 291 |
| abstract_inverted_index.aged | 59 |
| abstract_inverted_index.card | 157 |
| abstract_inverted_index.each | 132 |
| abstract_inverted_index.have | 11, 294 |
| abstract_inverted_index.less | 261 |
| abstract_inverted_index.need | 310, 324 |
| abstract_inverted_index.odds | 236, 251 |
| abstract_inverted_index.past | 31, 256 |
| abstract_inverted_index.run. | 133 |
| abstract_inverted_index.spot | 103 |
| abstract_inverted_index.than | 262 |
| abstract_inverted_index.that | 9 |
| abstract_inverted_index.used | 112, 226 |
| abstract_inverted_index.were | 64 |
| abstract_inverted_index.with | 186, 201, 255 |
| abstract_inverted_index.(DBS) | 104 |
| abstract_inverted_index.(DRC) | 47 |
| abstract_inverted_index.(IgG) | 97 |
| abstract_inverted_index.0.05. | 218 |
| abstract_inverted_index.0.053 | 195 |
| abstract_inverted_index.0.088 | 211 |
| abstract_inverted_index.1.70, | 273 |
| abstract_inverted_index.792), | 214 |
| abstract_inverted_index.8.78) | 274 |
| abstract_inverted_index.Assay | 118 |
| abstract_inverted_index.Congo | 46 |
| abstract_inverted_index.Score | 119 |
| abstract_inverted_index.These | 306 |
| abstract_inverted_index.above | 140 |
| abstract_inverted_index.among | 37, 175, 275, 286 |
| abstract_inverted_index.being | 139 |
| abstract_inverted_index.below | 142, 239 |
| abstract_inverted_index.blood | 102 |
| abstract_inverted_index.child | 254 |
| abstract_inverted_index.could | 10 |
| abstract_inverted_index.dated | 155 |
| abstract_inverted_index.dried | 101 |
| abstract_inverted_index.fully | 277 |
| abstract_inverted_index.level | 265 |
| abstract_inverted_index.model | 224 |
| abstract_inverted_index.ratio | 125 |
| abstract_inverted_index.that, | 285 |
| abstract_inverted_index.using | 90 |
| abstract_inverted_index.while | 184 |
| abstract_inverted_index.whose | 62 |
| abstract_inverted_index.(DHS). | 52 |
| abstract_inverted_index.0.085, | 183 |
| abstract_inverted_index.3-dose | 165 |
| abstract_inverted_index.6–59 | 60, 288 |
| abstract_inverted_index.CD150+ | 23 |
| abstract_inverted_index.Health | 50 |
| abstract_inverted_index.Recent | 2 |
| abstract_inverted_index.Survey | 51 |
| abstract_inverted_index.child. | 80 |
| abstract_inverted_index.entire | 177 |
| abstract_inverted_index.having | 238, 260 |
| abstract_inverted_index.immune | 7 |
| abstract_inverted_index.impact | 297, 316 |
| abstract_inverted_index.levels | 36, 241, 299 |
| abstract_inverted_index.median | 145, 170, 192, 208, 240, 264 |
| abstract_inverted_index.memory | 19 |
| abstract_inverted_index.months | 61, 289 |
| abstract_inverted_index.obtain | 114 |
| abstract_inverted_index.random | 220 |
| abstract_inverted_index.recall | 92 |
| abstract_inverted_index.sample | 54, 144, 178 |
| abstract_inverted_index.status | 151 |
| abstract_inverted_index.value. | 148 |
| abstract_inverted_index.within | 75 |
| abstract_inverted_index.DRC’s | 331 |
| abstract_inverted_index.Methods | 25 |
| abstract_inverted_index.Mothers | 68 |
| abstract_inverted_index.P-value | 216 |
| abstract_inverted_index.Results | 168 |
| abstract_inverted_index.Tetanus | 134, 149 |
| abstract_inverted_index.amnesia | 8 |
| abstract_inverted_index.between | 30, 231 |
| abstract_inverted_index.control | 129 |
| abstract_inverted_index.disease | 234 |
| abstract_inverted_index.effects | 14 |
| abstract_inverted_index.examine | 228 |
| abstract_inverted_index.history | 72, 187, 203, 257 |
| abstract_inverted_index.limited | 159 |
| abstract_inverted_index.measles | 32, 74, 87, 94, 189, 205, 233, 259, 292, 332 |
| abstract_inverted_index.mothers | 63 |
| abstract_inverted_index.recall) | 71 |
| abstract_inverted_index.results | 116, 283 |
| abstract_inverted_index.series. | 167 |
| abstract_inverted_index.studies | 3, 313 |
| abstract_inverted_index.suggest | 4, 284, 308 |
| abstract_inverted_index.tetanus | 34, 173, 243, 267 |
| abstract_inverted_index.&lt; | 217 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Republic | 44 |
| abstract_inverted_index.antibody | 35, 268 |
| abstract_inverted_index.authors: | 337 |
| abstract_inverted_index.children | 38, 58, 83, 161, 181, 185, 200, 276, 287 |
| abstract_inverted_index.complete | 164 |
| abstract_inverted_index.examined | 27 |
| abstract_inverted_index.findings | 307 |
| abstract_inverted_index.immunity | 303, 320 |
| abstract_inverted_index.included | 130 |
| abstract_inverted_index.lifetime | 77 |
| abstract_inverted_index.logistic | 222 |
| abstract_inverted_index.maternal | 91 |
| abstract_inverted_index.obtained | 99, 153 |
| abstract_inverted_index.platform | 110 |
| abstract_inverted_index.positive | 128 |
| abstract_inverted_index.previous | 232 |
| abstract_inverted_index.program. | 334 |
| abstract_inverted_index.reported | 69, 339 |
| abstract_inverted_index.selected | 65 |
| abstract_inverted_index.serology | 146, 174 |
| abstract_inverted_index.tetanus. | 280, 305 |
| abstract_inverted_index.analysis. | 105 |
| abstract_inverted_index.antibody. | 244 |
| abstract_inverted_index.completed | 89 |
| abstract_inverted_index.consisted | 55 |
| abstract_inverted_index.continued | 326 |
| abstract_inverted_index.depletion | 17 |
| abstract_inverted_index.examining | 314 |
| abstract_inverted_index.intercept | 221 |
| abstract_inverted_index.long-term | 12, 296 |
| abstract_inverted_index.multiplex | 107 |
| abstract_inverted_index.potential | 247 |
| abstract_inverted_index.receiving | 162 |
| abstract_inverted_index.serologic | 115 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 281 |
| abstract_inverted_index.Democratic | 43 |
| abstract_inverted_index.calculated | 122 |
| abstract_inverted_index.chi-square | 215 |
| abstract_inverted_index.evaluation | 327 |
| abstract_inverted_index.interview. | 67 |
| abstract_inverted_index.laboratory | 312 |
| abstract_inverted_index.measles’ | 315 |
| abstract_inverted_index.previously | 85 |
| abstract_inverted_index.regression | 223 |
| abstract_inverted_index.serostatus | 98, 135 |
| abstract_inverted_index.underscore | 322 |
| abstract_inverted_index.vaccinated | 278 |
| abstract_inverted_index.variables, | 249 |
| abstract_inverted_index.2013–2014 | 42 |
| abstract_inverted_index.Controlling | 245 |
| abstract_inverted_index.Demographic | 48 |
| abstract_inverted_index.Disclosures | 335 |
| abstract_inverted_index.association | 29, 230 |
| abstract_inverted_index.categorized | 137 |
| abstract_inverted_index.confounding | 248 |
| abstract_inverted_index.immunoassay | 109 |
| abstract_inverted_index.improvement | 329 |
| abstract_inverted_index.vaccination | 150, 156, 166, 333 |
| abstract_inverted_index.disclosures. | 340 |
| abstract_inverted_index.lymphocytes. | 24 |
| abstract_inverted_index.preferential | 16 |
| abstract_inverted_index.participating | 39 |
| abstract_inverted_index.pre-existing, | 301, 318 |
| abstract_inverted_index.Classification | 81 |
| abstract_inverted_index.immunoglobulin | 95 |
| abstract_inverted_index.measles-induced | 6 |
| abstract_inverted_index.vaccine-induced | 302, 319 |
| abstract_inverted_index.chemiluminescent | 108 |
| abstract_inverted_index.immunosuppressive | 13 |
| cited_by_percentile_year.max | 94 |
| cited_by_percentile_year.min | 89 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 10 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.800000011920929 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.52420966 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |